Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment.
The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment. Int J Mol Sci. 2021 Apr 26; 22(9).
View in:
PubMed
subject areas
Apoptosis
Cell Line
Cell Proliferation
DNA Damage
eIF-2 Kinase
Endoplasmic Reticulum Stress
Eukaryotic Initiation Factor-2
Glaucoma, Open-Angle
Humans
Protein Kinase Inhibitors
Unfolded Protein Response
authors with profiles
Steven L. Carroll
Dariusz Maciej Pytel